Royal Society of Chemistry, RSC Medicinal Chemistry, 11(12), p. 1958-1967, 2021
DOI: 10.1039/d1md00025j
Full text: Unavailable
C-Terminal modification of Leu-enkephalin analogs reduces β-arrestin signaling at the μ- and δ-opioid receptors. Such modifications will enable evaluation of novel signaling profiles for chronic pain management.